Cargando…

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway

Gallbladder cancer is the most common malignant tumor of the biliary system and is characterized by difficulty to diagnose in early stages, a high degree of malignancy, and poor prognosis. Finding new drugs may improve the prognosis for this dismal cancer. Herein, we investigated the potential appli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Chenhao, Wang, Yali, Li, Jiandong, Cen, Wenda, Zhang, Weiguang, Zhu, Zhiyang, Yu, Jianhua, Lu, Baochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902850/ https://www.ncbi.nlm.nih.gov/pubmed/33623100 http://dx.doi.org/10.1038/s41598-021-83924-4

Ejemplares similares

Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis
por: Li, Jiandong, et al.
Publicado: (2022)

Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells
por: Lin, Weiguo, et al.
Publicado: (2020)

Inhibition of heat shock protein 90 alleviates cholestatic liver injury by decreasing IL-1β and IL-18 expression
por: Tong, Chenhao, et al.
Publicado: (2021)

Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2
por: Cen, Wenda, et al.
Publicado: (2021)

Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling
por: Song, Xiaoling, et al.
Publicado: (2017)

Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
por: Zhai, Tianyu, et al.
Publicado: (2021)

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
por: Zhai, Tianyu, et al.
Publicado: (2021)

MDA-19 Suppresses Progression of Melanoma Via Inhibiting the PI3K/Akt Pathway
por: Dang, Ningning, et al.
Publicado: (2018)

Silencing of SPP1 Suppresses Progression of Tongue Cancer by Mediating the PI3K/Akt Signaling Pathway
por: Zhang, Qiaoli, et al.
Publicado: (2020)

Pterostilbene promotes mitochondrial apoptosis and inhibits proliferation in glioma cells
por: Gao, Haijun, et al.
Publicado: (2021)

SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021)

Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway
por: Tan, Wenliang, et al.
Publicado: (2017)

LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway
por: Xu, Debin, et al.
Publicado: (2022)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021)

Glycoprotein M6A Suppresses Lung Adenocarcinoma Progression via Inhibition of the PI3K/AKT Pathway
por: Zhang, Qian, et al.
Publicado: (2022)

Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway
por: Shi, Ni, et al.
Publicado: (2019)

Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway
por: Hao, Jiaqi, et al.
Publicado: (2017)

Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells
por: Chen, Kunlun, et al.
Publicado: (2021)

LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway
por: Wang, Danfang, et al.
Publicado: (2022)

Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway
por: Feng, Guofei, et al.
Publicado: (2023)

Pterostilbene in Cancer Therapy
por: Obrador, Elena, et al.
Publicado: (2021)

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance
por: Zhai, Xiangyu, et al.
Publicado: (2022)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway
por: Wang, Yue, et al.
Publicado: (2022)

Knockdown of STIL suppresses the progression of gastric cancer by down‐regulating the IGF‐1/PI3K/AKT pathway
por: Wang, Ju, et al.
Publicado: (2019)

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2020)

Propofol suppresses adipose-derived stem cell progression via PI3K/AKT-Wnt signaling pathway
por: Yin, Guoping, et al.
Publicado: (2022)

Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis
por: Wang, Ying-Jan, et al.
Publicado: (2017)

KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer
por: Wei, Dang, et al.
Publicado: (2021)

Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
por: Mickymaray, Suresh, et al.
Publicado: (2021)

Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
por: Shan, Hui, et al.
Publicado: (2022)

Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma
por: Liu, Juan, et al.
Publicado: (2014)

miR-185 suppresses progression of Ewing’s sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways
por: Zhang, Shuai, et al.
Publicado: (2018)

Knockdown of MMP-1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c-myc signaling pathway and EMT
por: Wang, Kai, et al.
Publicado: (2020)

Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway
por: Wang, Zijie, et al.
Publicado: (2021)

Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer
por: Qian, Liqiang, et al.
Publicado: (2020)

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
por: Li, Hefei, et al.
Publicado: (2021)

PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
por: Fang, Wenfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j8q0chq1m1q159veeah1mo4vok